Form 4: Dolby SVP Sells Shares Under 10b5-1 Plan

Dolby Laboratories' SVP of Entertainment, John D. Couling, sold 7,273 shares of Class A Common Stock for $68.75 per share under a pre-arranged 10b5-1 trading plan.

Summary

• John D. Couling, SVP, Entertainment at Dolby Laboratories, Inc. (DLB), reported a sale of Class A Common Stock.
• The transaction involved the disposition of 7,273 shares.
• The shares were sold at a price of $68.75 per share.
• The transaction occurred on December 11, 2025.
• The sale was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following this transaction, John D. Couling beneficially owns 108,065 shares of Class A Common Stock.
• The beneficially owned shares include 48,526 shares of Class A common stock underlying restricted stock units (RSUs), which are subject to forfeiture until they vest.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale under a pre-arranged 10b5-1 plan, which is generally considered a neutral event and does not indicate a positive or negative sentiment towards the company's performance or outlook.

Future Outlook

No forward-looking statements or guidance were provided in this filing, as it pertains solely to an insider transaction.

Industry Context

This filing reports a routine insider stock transaction and does not provide information directly related to broader industry trends or competitive positioning for Dolby Laboratories. Such sales are common for executives managing personal finances and diversifying holdings.

Stakeholder Impact

• Shareholders: A routine insider sale under a 10b5-1 plan typically has minimal direct impact on shareholders, as it is often pre-scheduled and not indicative of a change in company fundamentals or management's confidence.

Key Dates

Keywords

Dolby Laboratories, DLB, Insider Transaction, Form 4, Stock Sale, 10b5-1 Plan, Executive Compensation